Chad M. Robins, CEO and Chairman at Adaptive Biotechnologies Corp (ADPT), sold 570,374 shares at $8.44 ($4.8M) on 2025-02-20, disclosed to the SEC on 2025-02-21.
Scheduled sale ($4.8M) by CEO and Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.46 | 186,080 | $1.6M | 32.7% |
| 2 | $8.46 | 186,080 | $1.6M | 32.7% |
| 3 | $8.44 | 99,107 | $836K | 17.3% |
| 4 | $8.44 | 99,107 | $836K | 17.3% |
| Total | $8.45 avg | 570,374 | $4.8M | 100% |
| Filing → |
| ADPT | SELL | 2026-03-13 | $6.2M | — | Filing → |
| ADPT | SELL | 2026-03-03 | $8.3M | — | Filing → |
| ADPT | SELL | 2026-02-04 | $2.3M | — | Filing → |